Skip to main content
. 2024 Feb 12;15(3):389–399. doi: 10.1007/s13340-023-00686-2

Table 1.

Clinical and biochemical parameters of the studied groups

Parameter GR I Control
n = 25
GR II Normoalbuminuria
n = 25
GR III Microalbuminuria
n = 25
GR IV Macroalbuminuria
n = 25
p-value
Age 50 ± 5.31 52.64 ± 6.25 52.76 ± 7.64 55.24 ± 6.25 0.051
Sex (f/m %) 15/10 (60/40) 16/9 (64/36) 14/11 (56/44) 12/13 (48/52) 0.699
Diabetes duration (years) 6.72 ± 1.54 8.76 ± 2b 11.2 ± 2.61bc  < 0.001*
SBP (mmHg) 120.7 ± 8 127.5 ± 11 134 ± 9ab 138 ± 10.5abc  < 0.001*
DBP (mmHg) 69.5 ± 4.9 72 ± 5.3 78.2 ± 7.2ab 82.8 ± 7.9abc  < 0.001*
FBG (mg/dl) 86.91 ± 6.98 207.56 ± 58.7a 229.5 ± 66.7a 233.4 ± 40.6a  < 0.001*
PBG (mg/dl) 113.78 ± 12.37 301 ± 68.4a 325 ± 63.8a 334.32 ± 54.54a  < 0.002*
HbA1C (%) 5.1 ± 0.2 8.7 ± 1.4a 10.1 ± 1.2ab 10.4 ± 1.09ab  < 0.001*
ACR (mg/g creatinine) 4.7 ± 1.83 18.49 ± 4.9a 115.33 ± 59.4ab 717.3 ± 163.55abc  < 0.001*
Cystatin-C (mg/l) 0.79 ± 0.1 0.86 ± 0.14 1.11 ± 0.26ab 2.3 ± 0.61abc  < 0.001*

eGFR

(ml/min/1.73m2)

88.03 ± 13.02 77.61 ± 14.8 68.6 ± 15a 44.2 ± 15.8abc  < 0.001*
Creatinine (mg/dl) 1.016 ± 0.13 1.09 ± 0.15 1.25 ± 0.21ab 1.99 ± 0.65abc  < 0.001*
BUN (mg/dl) 14 ± 2.6 17.19 ± 4.21a 19.06 ± 5.66a 38 ± 16abc  < 0.001*
Na+ (mmol/l) 14 0.5 ± 2.5 142.46 ± 2a 144.52 ± 3.1ab 141.54 ± 4.77  < 0.001*
K+ (mmol/l) 4.18 ± 0.26 4.09 ± 0.29 4.36 ± 0.56 4.48 ± 0.88 0.068
Cholesterol (mg/dl) 183.26 ± 17.28 208.83 ± 32.95a 221.4 ± 45.35a 239.16 ± 64.81a  < 0.001*
Triglyceride (mg/dl) 127.48 ± 20.15 160 ± 29.6a 171.9 ± 42a 182.72 ± 59.76a  < 0.001*
HDL-C (mg/dl) 50.64 ± 6.55 45 ± 7.22a 42 ± 5.7a 37.2 ± 5.26abc  < 0.001*
LDL-C (mg/dl) 107.12 ± 20.6 131.81 ± 42.46a 145 ± 50.95a 165.41 ± 76a  < 0.001*

Urinary uromodulin

(μg/ml)

18.04 ± 2.72 25.24 ± 3.54a 33.05 ± 7.98ab 20.82 ± 2.55abc  < 0.001*
uUCR (mg/g creatinine) 12.4 ± 5.5 26.3 ± 10.4a 40.6 ± 25.7ab 24.5 ± 17.6abc  < 0.001*
Exosomal UMOD gene 0.51(0.21–0.9) 2.87(2.51–3.7)a 4.75(3.82–9.7)ab 3.7(2.54–6.7)ac  < 0.001*

Clinical parameters represented as mean ± S.D., exosomal UMOD gene represented as median (IQR), significance at p-value (< 0.05), ap < 0.05 vs. control group, bp < 0.05 vs. normoalbuminuria group (GR II), cp < 0.05 vs. microalbuminuria group (GR III)

SBP systolic blood pressure, DBP diastolic blood pressure, ACR albumin to creatinine ratio, eGFR estimated glomerular filtration rate, BUN blood urea nitrogen, HDL high-density lipoprotein, LDL low-density lipoprotein, uUCR urinary uromodulin to creatinine ratio